← Back to headlines
Innovent and Eli Lilly Partner to Commercialize Verzenios in China
Innovent Biologics and Eli Lilly have partnered to commercialize Verzenios (abemaciclib) in China, expanding access to the cancer treatment in the region.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Trump Administration Announces Major Oil Deal to Replenish U.S. Strategic Reserve
28m ago
NATO Warns of Escalating Russian Gray Zone Attacks Across Europe
50m ago
Investors Eye Jobs Data and Major Earnings Reports for Market Direction
1h ago
North Korea Replaces Defense Minister in Military Shake-Up
2h ago